Cellab CDMO is a Contract Development and Manufacturing Organisation (CDMO) specialising in the development and manufacturing of cell and gene therapies. The company offers end-to-end services for Advanced Therapy Medicinal Products (ATMPs), supporting their clients from early-stage development to clinical programs and commercialization.

Cellab CDMO partners with biotech and pharmaceutical companies to deliver tailored solutions for cell and gene therapy products. With a focus on GMP compliance, the company provides services ranging from bioprocess design and scaling to manufacturing, quality control, and logistics. Cellab operates advanced facilities that cater to both autologous and allogenic cell therapies.

Key Products and Services

• Cell and gene therapy manufacturing
• GMP batch release and storage
• Process development and scale-up
• Aseptic fill and finish services
• Quality control and characterization (e.g., flow cytometry, endotoxin testing, potency assays)
• Regulatory assistance and EU batch release
• Cryogenic storage and logistics

Cellab CDMO’s flexibility, deep expertise in GMP and regulatory standards, and commitment to delivering high-quality therapies ensure their clients can realise the full potential of their products.